Adjuvant Chemotherapy in Elderly Patients With Breast Cancer: Weekly Docetaxel vs. CMF

Trial Profile

Adjuvant Chemotherapy in Elderly Patients With Breast Cancer: Weekly Docetaxel vs. CMF

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Docetaxel (Primary) ; Cyclophosphamide; Fluorouracil; Methotrexate
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms ELDA
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Aug 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 12 Jul 2012 Actual patient number changed from 101 to 300 as reported by ClinicalTrials.gov.
    • 12 Jul 2012 Planned end date changed from 1 Jun 2010 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top